Sign In

Melanie Mahtani

Serial entrepreneur in Genomics & Personalized Medicine

Melanie Mahtani is a renowned serial entrepreneur and human genetics/genomics expert with a strong background in diagnostics technology development and commercialization. She has a wealth of experience in leading strategy and execution of genomic-based diagnostics and businesses, with a profound commitment to revolutionizing healthcare through genomics. Melanie has a remarkable track record of success in the genomics industry, having spearheaded high-performing companies and teams to various technological advancements, acquisitions, and commercial triumphs. She has raised over $200 million in capital, introduced more than 36 groundbreaking genomic products and technologies, and generated over $2 billion in value. Melanie has held key leadership roles in prominent biotech and diagnostics companies like Amersham (acquired by GE Healthcare), Verinata (acquired by Illumina), Siemens, Roche, CellScape, Diagenode, Panomics (acquired by Affymetrix), Med BioGene (acquired by Precision Therapeutics), and Iconix (acquired by Entelos), among others.

Melanie Mahtani
Add to my network

Location

Palo Alto, California, United States